Archive for ◊ May, 2011 ◊

Author:
• Friday, May 20th, 2011

Investing in a medical device company these days does not come cheap. Venture capitalists said at a panel during Thursday’s MedTech Investing Conference in Minneapolis that the cost and risk of bringing medical device start-ups to market has gotten so expensive, it has caused at least one of them to change their business model. Jan Garfinkle, […]

Author:
• Friday, May 20th, 2011

Premia Spine, Ltd. announced today that the company acquired Impliant, Ltd. assets, which include 16 worldwide patents. Premia intends to commercially launch the TOPS(TM) System and its adjunct Versalink(TM) Fixation System in third quarter of 2011.   “We are excited about the opportunity to provide patients with a clinically-proven, superior solution to lumbar fusion,” stated […]

Author:
• Friday, May 20th, 2011

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the EXOSEAL™ Vascular Closure Device in the US. EXOSEAL™ incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure.   ”We are very pleased to announce […]

Author:
• Friday, May 20th, 2011

In a letter to federal regulators yesterday, Carlsbad, CA-based AutoGenomics withdrew its filing for an initial public offering, which the company submitted in July, 2008. The company said at that time that its IPO would be made only by means of a prospectus, with J.P. Morgan Securities Inc. acting as the sole book-running manager of the offering. CEO […]

Author:
• Thursday, May 19th, 2011

The Tijuana Economic Development Council (Tijuana EDC) recently published a White Paper that highlights an annual growth of 8.7% in employment of the Medical Device sector since 2004, reaching over 30,000 workers, concentrated in 40 medical manufacturing companies, such as Care Fusion, Medtronic, DJO Global and GreatBatch among others. This number makes Tijuana the premier […]

Author:
• Thursday, May 19th, 2011

DUBLIN, May 17, 2011 /PRNewswire-FirstCall/ — Shire plc (LSE:SHP.l – News), the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire Advanced BioHealing, Inc.   – Creation of a new strategic platform based on tissue regeneration using cell-based therapies complements Shire’s existing specialty focus and biologics manufacturing capability   – Strong […]

Author:
• Thursday, May 19th, 2011

Medical device company Baxter Canada will close its Sherbrooke, Que., plant on Dec. 9, putting 135 people out of work. The company plans to relocate production to other plants in the United States, Costa Rica and Singapore that are already making its products. The Sherbrooke plant made medical devices for intravenous interventions.   http://www.metronews.ca/vancouver/business/article/864598–baxter-canada-shuts-sherbrooke-plant

Author:
• Thursday, May 19th, 2011

The FDA warns a trio of companies that offer direct-to-consumer genetic tests on medical claims made in their marketing campaigns. The FDA formally warned three providers of direct-to-consumer DNA tests about medical claims the companies make that the federal watchdog agency hasn’t approved. The FDA wants the companies; American International Biotechnology Services, Lumigenix Inc and […]

Author:
• Tuesday, May 17th, 2011

Biomedical engineersdeveloped a robotic arm to very precisely resurface the kneebefore replacing it. In order to do this, a 3-D image of the knee is generated, providing a live-action view of the knee duringsurgery. A stereo camera system constantly updatessurgeons on the location of the diseased portion of the knee–this keeps the healthy parts untouched. Visual alarms and artificial resistance tell […]

Author:
• Tuesday, May 17th, 2011

Orthopedic implant and surgical products maker Stryker Corp. said Monday it will buy rival Orthovita Inc. for about $304 million in cash. Orthovita’s products include Vitoss bone grafts and Cortoss bone augmentation material. It also sells Vitagel, which is designed to reduce bleeding. Stryker is offering $3.85 per share, a premium of 41 percent from […]